Cutera's New truSculpt iD Offers Personalized Body Sculpting
Cutera, Inc's new truSculpt® iD offers an evolution in body sculpting with unique hands-free capability and the ability to treat a full abdomen in as little as 15 minutes. truSculpt iD offers physicians and other qualified practitioners the flexibility to deliver personalized body sculpting to patients through either a hand-held or hands-free treatment technique in a fraction of the time required by other body sculpting options on the market. This, alongside its unique ability to treat various fat densities and all skin types, highlights the versatility of the truSculpt® iD technology.
A non-surgical body sculpting system, truSculpt iD uses innovative monopolar radio frequency (RF) technology to selectively target fat and therapeutically heat it until fat cells are slowly removed and excreted through the body naturally. Penetrating deep to treat the entire fat layer from skin to muscle, truSculpt iD is clinically proven for permanent fat cell destruction. With real time temperature control working to provide consistent results, studies have shown an average fat reduction of 24 percent, with patients seeing improvements six to 12 weeks following the first treatment.
“truSculpt iD allows patients to achieve truly tailored results in a significantly shorter time frame, making it a very appealing non-invasive option for permanently eliminating fat cells in stubborn areas,” says Dr. Anne Chapas, internationally acclaimed dermatologic surgeon and Medical Director of Union Square Laser Dermatology. “With such an efficient technology and the ability to treat multiple body areas simultaneously, we are able to treat more patients in a shorter period of time as a result.”
The launch of truSculpt ® iD comes at a time of significant growth for the industry. Research shows non-surgical fat reduction was the top non-surgical and non-invasive procedure in 2017, with procedures increasing by 24.7 percent. Looking ahead, the body shaping and skin tightening market is expected to expand by 14.5 percent year-over-year.
“We are proud to announce the availability of truSculpt ® iD, supporting our mission to develop powerful technologies that advance the medical aesthetics industry and help clinicians expand their body sculpting practice,” says James Reinstein, President and CEO of Cutera, Inc. “truSculpt ® iD delivers results regardless of the patient’s shape or body type - allowing physicians to effectively treat those who might not be candidates for other contouring procedures. We believe the truSculpt ® iD will expand the market with this comfortable, safe, and highly accelerated sculpting procedure. Additionally, truSculpt ® iD further enhances our expanding portfolio of devices which incorporate a disposable element. These new consumables allow us to participate in procedure-based recurring revenue along with our physician customers.”